AppBlogHilfeonvista bank
Werbung ausblenden

News zu Acticor Biotech Actions Nom. EO 1

ACTICOR BIOTECH: Postponement of the Publication of Annual Results and Universal Registration Document 2023 · Uhr · Business Wire
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of February 28, 2022 · Uhr · Business Wire
Acticor Biotech Announces Positive Results From Its ACTIMIS PHASE 1b/2a Study in Patients With Acute Ischemic Stroke (AIS) · Uhr · Business Wire
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of January 31, 2022 · Uhr · Business Wire
Acticor Biotech: Results of the Phase 2 GARDEN Study in COVID-19-Related Acute Respiratory Distress Syndrome · Uhr · Business Wire
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares · Uhr · Business Wire
ACTICOR BIOTECH: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux · Uhr · Business Wire
Acticor Biotech Announces Coverage of Its Stock by Gilbert Dupont and Kepler Cheuvreux · Uhr · Business Wire
Acticor Biotech Announces Its 2022 Financial Agenda · Uhr · Business Wire
Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke · Uhr · Business Wire
Werbung ausblenden